Group 1 - The company, 朸濬国际 (01355), announced that all conditions for the placement have been met, and the completion was realized on September 25, 2025 [1] - A total of 199 million shares were placed, which represents approximately 16.66% of the company's issued share capital after the placement [1] - The shares were successfully placed to no less than six subscribers at a placement price of HKD 0.063 per share according to the terms of the placement agreement [1]

Core Viewpoint - The company,朸浚国际, has successfully completed a placement of 198 million shares at a price of HKD 0.063 per share, raising approximately HKD 12.37 million for further development in its healthcare and beauty business [1] Group 1: Placement Details - The placement involved 198 million shares, representing about 16.66% of the company's enlarged issued share capital post-placement [1] - The shares were successfully placed to no fewer than six subscribers according to the terms of the placement agreement [1] - The net proceeds from the placement, after deducting related expenses, amount to approximately HKD 12.37 million, equating to a net issue price of about HKD 0.0622 per share [1] Group 2: Use of Proceeds - The company plans to utilize the entire net proceeds for further development in its healthcare and beauty business, as previously disclosed in announcements [1]

Core Viewpoint - The company, 朴濬国际 (01355), has successfully completed a placement of shares, fulfilling all conditions of the placement agreement as of September 25, 2025 [1] Summary by Relevant Sections - The company has placed a total of 199 million shares, which represents approximately 16.66% of the enlarged issued share capital following the completion of the placement [1] - The shares were successfully placed at a price of HKD 0.063 per share to no fewer than six subscribers as per the terms of the placement agreement [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 LEGEND STRATEGY INTERNATIONAL HOLDINGS GROUP COMPANY LIMITED 朸濬國際集團控股有限公司 （於開曼群島註冊成立之有限公司） （股份代號：1355） 完成根據一般授權配售新股份 經董事作出一切合理查詢後深知、全悉及確信，(i)各名承配人及（如適用）其各 自的最終實益擁有人均為獨立第三方；及(ii)概無承配人於完成後成為了主要 股東（定義見上市規則）。 經扣除相關開支（包括但不限於配售佣金、法律開支及付款）後，配售事項之 所得款項淨額約為12,370,000港元，相當於每股配售股份發行淨價約0.0622港 元。本公司擬按照先前於該等公告披露的方式動用全部所得款項淨額，即將 用於本集團醫療保健及美容業務的進一步發展。 對本公司股權架構之影響 下表載列於緊接完成前及完成後本公司股權架構的變動： | 股東 | 於緊接配售事項完成前 | | 於緊接配售事項完 ...

LEGEND STRATEGY INTERNATIONAL HOLDINGS GROUP COMPANY LIMITED 朸 濬 國 際 集 團 控 股 有 限 公 司 （ Incorporated in the Cayman Islands with limited liability ） （於開曼群島註冊成立之有限公司） （Stock Code 股份代號：1355） NOTIFICATION LETTER 通 知 信 函 Dear Non-registered Shareholder (Note 1) , 16 September 2025 You may at any time send your request in writing to the Company (c/o its Hong Kong Share Registrar, Union Registrars Limited ("Hong Kong Share Registrar") at Suites 3301-04, 33/F., Two Chinachem Exchange Square, 338 King's Road, North P ...

LEGEND STRATEGY INTERNATIONAL HOLDINGS GROUP COMPANY LIMITED 朸 濬 國 際 集 團 控 股 有 限 公 司 （ Incorporated in the Cayman Islands with limited liability （於開曼群島註冊成立之有限公司） （Stock Code 股份代號：1355） NOTIFICATION LETTER 通 知 信 函 Dear Shareholder(s), 16 September 2025 The following document(s) of Legend Strategy International Holdings Group Company Limited ("Company") has/have been prepared in English and Chinese and is/are available on the websites of the Company at www.legend-strategy.com and The Stock Exchange of Hong Ko ...

[CORPORATE INFORMATION](index=3&type=section&id=CORPORATE%20INFORMATION) [Directors and Committee Composition](index=3&type=section&id=Directors%20and%20Committees) The company's board of directors comprises executive, non-executive, and independent non-executive directors, supported by audit, nomination, and remuneration committees to ensure robust corporate governance - Executive Director is **Ms. Li Zhi Xin**[3](index=3&type=chunk) - Non-executive Directors include Chairman **Mr. Yuan Fuaer** and **Mr. Hu Xinglong**[3](index=3&type=chunk) - Independent Non-executive Directors include **Mr. Wu Jilin** (Audit Committee Chairman), **Mr. Lin Changsheng** (Nomination Committee Chairman), and **Mr. Su Yanwei** (Remuneration Committee Chairman)[3](index=3&type=chunk)[4](index=4&type=chunk) [Company Details](index=4&type=section&id=Company%20Details) The company's principal bankers include Industrial Bank in China and Hang Seng Bank, Bank of China (Hong Kong), and Bank of Communications (Hong Kong) in Hong Kong, with auditors being National Alliance CPA Limited and stock code 1355 - Principal bankers include **Industrial Bank Co., Ltd.** in China, and **Hang Seng Bank Limited**, **Bank of China (Hong Kong) Limited**, and **Bank of Communications (Hong Kong) Limited** in Hong Kong[5](index=5&type=chunk)[6](index=6&type=chunk) - Auditor is **National Alliance CPA Limited**[6](index=6&type=chunk)[7](index=7&type=chunk) - Company stock code is **1355**, website is **www.legend-strategy.com**[8](index=8&type=chunk)[9](index=9&type=chunk) [MANAGEMENT DISCUSSION AND ANALYSIS](index=6&type=section&id=MANAGEMENT%20DISCUSSION%20AND%20ANALYSIS) [Business Review](index=6&type=section&id=BUSINESS%20REVIEW) The Group primarily operates accommodation and healthcare and beauty businesses, with accommodation revenue declining by **28.9%** due to global instability, while healthcare and beauty contributed approximately **HKD 11,886,000** in revenue - The Group primarily engages in accommodation business (including accommodation operation, property facilities management, and accommodation consulting services) and healthcare and beauty business[10](index=10&type=chunk)[12](index=12&type=chunk) - For the six months ended June 30, 2025, the Group operated **five** leased accommodation projects[10](index=10&type=chunk)[12](index=12&type=chunk) [Accommodation Business](index=6&type=section&id=ACCOMMODATION%20BUSINESS) Accommodation business revenue decreased by **28.9%** year-on-year due to global economic instability and geopolitical conflicts, with the Nanshan store closure generating approximately **HKD 1,920,000** in early lease termination income - The hotel business continues to be affected by global economic instability and geopolitical conflicts, particularly China's economic slowdown and weakened consumer sentiment[11](index=11&type=chunk)[13](index=13&type=chunk) - The Group adopts flexible sales and marketing strategies to improve existing accommodation project performance and promotes sustainable high-quality corporate development through enhanced management, cost control, and expense reduction[11](index=11&type=chunk)[13](index=13&type=chunk) [Accommodation Operation and Property Facilities Management](index=7&type=section&id=Accommodation%20Operation%20and%20Property%20Facilities%20Management) Accommodation operation and property facilities management revenue was approximately **HKD 13,579,000**, a **28.9%** year-on-year decrease, primarily due to lower occupancy rates and reduced consulting service income in China's hotel market Accommodation Operation and Property Facilities Management Revenue | Metric | H1 2025 (HKD) | H1 2024 (HKD) | Change Rate | | :--- | :--- | :--- | :--- | | Revenue | 13,579,000 | 19,104,000 | -28.9% | - Revenue decrease primarily attributed to lower occupancy rates due to declining overall market sentiment in China's hotel industry, and reduced accommodation consulting service income[14](index=14&type=chunk)[18](index=18&type=chunk) - The Group enhances customer loyalty by collaborating with new travel intermediaries, updating sales strategies, offering preferential pricing models, deepening understanding of customer needs, and providing customized services[16](index=16&type=chunk)[19](index=19&type=chunk) [Branch Performance Overview](index=8&type=section&id=Branch%20Performance%20Overview) The Group's accommodation branches employ flexible strategies, with Chengdu benefiting from tourism recovery, Wuhan operating steadily, Huizhou anticipating Greater Bay Area growth, Nanshan generating **HKD 1,920,000** from lease termination, and Bao'an maintaining stability through cost control - The Chengdu store, located in the prime Tianfu Square business district, benefits from Chengdu's economic recovery and rebound in tourism consumer confidence, expecting sustained stable income in the future[20](index=20&type=chunk)[21](index=21&type=chunk)[22](index=22&type=chunk) - The Wuhan store, a transportation hub, experienced a slight demand decrease due to domestic economic development difficulties but achieved expected results in adversity through strengthened management, marketing, and cost optimization[23](index=23&type=chunk)[24](index=24&type=chunk)[26](index=26&type=chunk) - The Huizhou store, focusing on the resort tourism market, anticipates that Greater Bay Area development and international projects (such as Shenzhen East Legoland Theme Park) will drive tourist growth and long-term performance improvement[25](index=25&type=chunk)[27](index=27&type=chunk)[28](index=28&type=chunk)[32](index=32&type=chunk) - The Nanshan store ceased operations due to property repossession by the landlord for redevelopment, with approximately **HKD 1,920,000** in early lease termination income recognized this period[30](index=30&type=chunk)[33](index=33&type=chunk) - The Bao'an store maintained stable operating performance in adversity, benefiting from effective cost control and sales strategies[34](index=34&type=chunk)[35](index=35&type=chunk)[40](index=40&type=chunk) [Accommodation Consulting Services](index=11&type=section&id=Accommodation%20Consultations%20Services) Accommodation consulting services generated zero revenue this period, a significant decline from the prior year, leading the Group to reduce marketing investment and reallocate resources to the more promising healthcare and beauty business Accommodation Consulting Services Revenue | Metric | H1 2025 (HKD) | H1 2024 (HKD) | | :--- | :--- | :--- | | Revenue | 0 | 1,126,000 | - Given the reduced demand for such services, the Group will decrease marketing investment to save operating costs and reallocate resources to the healthcare and beauty business segment[37](index=37&type=chunk)[41](index=41&type=chunk) [Healthcare and Beauty Business](index=11&type=section&id=HEALTHCARE%20AND%20BEAUTY%20BUSINESS) The Group, through its wholly-owned subsidiary Shenzhen Yalansi Biotechnology Co. Ltd., generated approximately **HKD 11,886,000** in revenue this period by directly selling and promoting own-brand and third-party healthcare and beauty products in China - The Group will continue to develop its healthcare and beauty business through collaborations with key industry players and the development of proprietary rights and technologies[38](index=38&type=chunk)[42](index=42&type=chunk) Healthcare and Beauty Business Revenue | Metric | H1 2025 (HKD) | H1 2024 (HKD) | | :--- | :--- | :--- | | Revenue | 11,886,000 | 0 | - During this period, this business generated approximately **HKD 11,886,000** in revenue by directly selling and promoting own-brand products in China through Shenzhen Yalansi Biotechnology Co. Ltd.[39](index=39&type=chunk)[42](index=42&type=chunk) [Outlook](index=12&type=section&id=OUTLOOK) The Group plans to expand its market share in China's healthcare and beauty sector and explore international sales, considering an equity acquisition of an R&D platform for technology and competitive advantage, though no final agreement has been reached - The Group will further develop and strengthen its market share in China's healthcare and beauty industry and seek opportunities to expand sales to other regions[44](index=44&type=chunk)[47](index=47&type=chunk) - The Group is considering acquiring an equity interest in an R&D platform to gain cutting-edge technology and maintain a competitive advantage[44](index=44&type=chunk)[47](index=47&type=chunk) - As of the date of this interim report, no decision has been made or final agreement reached regarding the potential acquisition, and shareholders and potential investors are urged to exercise caution[45](index=45&type=chunk)[47](index=47&type=chunk) [Financial Review](index=12&type=section&id=FINANCIAL%20REVIEW) The Group's revenue increased by **33.2%** to approximately **HKD 25,445,000** this period, driven by healthcare and beauty, but a decline in accommodation revenue and non-financial asset impairment led to a **HKD 13,484,000** loss attributable to owners [Overall Financial Performance](index=12&type=section&id=Overall%20Financial%20Performance) The Group's revenue reached approximately **HKD 25,445,000**, a **33.2%** year-on-year increase, but reduced accommodation income and a **HKD 8,340,000** non-financial asset impairment resulted in a **HKD 13,484,000** loss attributable to owners, compared to a prior year profit of **HKD 3,211,000** Key Financial Indicators | Metric | H1 2025 (HKD) | H1 2024 (HKD) | Change Rate | | :--- | :--- | :--- | :--- | | Revenue | 25,445,000 | 19,104,000 | +33.2% | | Loss/(Profit) Attributable to Owners | (13,4

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 朸濬國際集團控股有限公司 呈交日期: 2025年9月10日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01355 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | FF3 ...

Core Viewpoint - The company, Pochun International (01355), plans to issue up to 199 million shares at a discount of approximately 11.27% to raise around HKD 12.37 million for the further development of its healthcare and beauty business [1] Group 1 - The company has entered into a placement agreement with a placement agent to facilitate the sale of shares [1] - The placement price is set at HKD 0.063 per share, compared to the closing price of HKD 0.071 on the date of the agreement [1] - The net proceeds from the placement are expected to be approximately HKD 12.37 million [1]

Group 1 - The company, Puhua International (01355.HK), has entered into a placement agreement with a placement agent to issue up to 198,840,000 shares at a price of HKD 0.063 per share [1] - The placement price represents a discount of approximately 11.27% compared to the closing price of HKD 0.071 per share on the date of the agreement [1] - The net proceeds from the placement, after deducting related costs, are expected to be approximately HKD 12.37 million, which will be used for the further development of the company's healthcare and beauty business [1]